XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
122 hedge funds and large institutions have $331M invested in Intersect ENT, Inc in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
57% less capital invested
Capital invested by funds: $776M → $331M (-$445M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
122
Holding in Top 10
1
Calls
$2.48M
Puts
$457K
Top Buyers
| 1 | +$18.7M | |
| 2 | +$9.69M | |
| 3 | +$8.31M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$7.06M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$4.79M |
Top Sellers
| 1 | -$63.2M | |
| 2 | -$39M | |
| 3 | -$29M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$7.95M |